Skip to main content

Gary M. Owens, MD

Authored Items
Challenges Facing the US Healthcare System in 2023 and Beyond: A Payer Perspective
Gary M. Owens, MD
September 2023 Vol 16, Payers' Guide to FDA Updates in A Payer Perspective
Multiple Sclerosis: Systemic Challenges to Cost-Effective Care
David R. Weinstein, PhD, Gary M. Owens, MD, Ankit Gandhi, PharmD
March 2022 Vol 15, No 1 - Online Only in Business, Review Article
Mental Health Conditions and Hospitalizations for Ambulatory Care Sensitive Conditions Among Veterans with Diabetes
Drew A. Helmer, MD, MS, Gary M. Owens, MD, Nilanjana Dwibedi, BPharm, MBA, PhD, Mazhgan Rowneki, MPH, Chin-Lin Tseng, DrPH, Dennis Fried, PhD, Danielle Rose, PhD, Nisha Jani, MPH, PhD, Usha Sambamoorthi, PhD
May 2020 Vol 13, No 2 in Clinical, Original Research
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States
Michael C. Runken, PharmD, Gary M. Owens, MD, Joshua M. Noone, PhD, Christopher M. Blanchette, PhD, MBA, Emily Zacherle, MS, Reuben Howden, PhD
October 2019 Vol 12, No 6 in Business, Original Research
The Challenge of Managing Atopic Dermatitis in the United States
Steven R. Feldman, MD, PhD, Gary M. Owens, MD, Linda S. Cox, MD, Lindsay C. Strowd, MD, Robert A. Gerber, PharmD, MA, MBA, Steven Faulkner, PharmD, MBA, Debra Sierka, PharmD, Timothy W. Smith, BA, Joseph C. Cappelleri, PhD, Mark E. Levenberg, DO
April 2019 Vol 12, No 2 in Clinical, Review Article
Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly
Sameer R. Ghate, PhD, Gary M. Owens, MD, Zhiyi Li, MBA, MA, Jackson Tang, MSc, Antonio Reis Nakasato, MD
October 2018 Vol 11, No 7 in Business, Original Research
Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study
Gary M. Owens, MD, Todd Williamson, PhD, MSc, Wendy Y. Cheng, MPhil, MPH, Nora McCormick, MSc, Francis Vekeman, MA
April 2018 Vol 11, No 2 in Clinical, Original Research
FDA Approvals in 2017 Represent a 21-Year High
Gary M. Owens, MD
March 2018, Vol 11, Ninth Annual Payers' Guide in FDA Approvals, Payers' Guide
Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor
JoAnne Foody, MD, Gary M. Owens, MD, Robin S. Turpin, PhD, Beni A. Tidwell, BS, Debra Lawrence, PhD, Kathy L. Schulman, MS
November 2017 Vol 10, No 8 in Clinical, Original Research
Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers
Burton S. Brodsky, MD, F. Randy Vogenberg, PhD, FASHP, Gary M. Owens, MD, Dennis J. Scotti, PhD, MBA, Keith A. Needham, BS, Christina L. Cool, MPH
October 2017 Vol 10, No 7 in Business, Original Research
Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide
Gary M. Owens, MD, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Dominic Pilon, MA, Yongling Xiao, PhD
September 2017 Vol 10, No 6 in Clinical, Original Research
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives
Steven R. Feldman, MD, PhD, Gary M. Owens, MD, Bernard Goffe, MD, Gary Rice, MBA, Matthew Mitchell, PharmD, MBA, FAMCP, Mandeep Kaur, MD, MS, Debbie Robertson, MS, RDN, LDN, Debra Sierka, PharmD, Jeffrey A. Bourret, PharmD, Tamara S. Evans, PharmD, MPH, BCPS, Alice Gottlieb, MD, PhD
December 2016 Vol 9, No 9 in Clinical
Treatment Patterns and Outcomes in Patients with Varicose Veins
Rajiv Mallick, PhD, Aditya Raju, MS, BPharm, Chelsey Campbell, PharmD, MBA, Rashad Carlton, PharmD, MSPH, David Wright, MD, Kimberly Boswell, MD, Michael Eaddy, PharmD, PhD, Gary M. Owens, MD
November 2016 Vol 9, No 8 in Clinical
Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain
Gary M. Owens, MD, Ancilla W. Fernandes, PhD, David M. Kern, PhD, Catherine Datto, MD, MS, Yen-Wen Chen, PhD, Charles McLeskey, MD, Ozgur Tunceli, PhD
May 2016 Vol 9, No 3 in Business
The Year 2015 Had Highest Number of Drug Approvals in the New Millennium, but with Controversy
Gary M. Owens, MD
March 2016, Vol 9, Seventh Annual Payers' Guide in FDA Approvals, Drug Updates, Payers' Guide
The Potential for Improved Prescribing: A Payer Perspective
Gary M. Owens, MD
Faculty Perspectives in Chronic Pain:Utilizing Pharmacogenomics When Selecting Personalized Medicine for Patients with Chronic Pain in Payers' Perspectives
Assessing Abuse-Deterrent Formulations: Much Work Still Remains
Gary M. Owens, MD
Faculty Perspectives in Chronic Pain: Epidemiologic Assessments of Abuse-Deterrent Formulations
In Vitro and Clinical Assessments of Abuse-Deterrent Formulations in the Management of Chronic Pain
Gary M. Owens, MD
Faculty Perspectives in Chronic Pain: In Vitro and Clinical Assessments of Abuse-Deterrent Formulations for Chronic Pain
Meeting the Challenges of Public Health Issues in Chronic Pain
Gary M. Owens, MD
Faculty Perspectives in Chronic Pain: Solutions to Public Health Issues in Chronic Pain
The Socioeconomic Burden of Patients with Chronic Pain
Gary M. Owens, MD
Faculty Perspectives in Chronic Pain: Socioeconomic Burden of Chronic Pain
Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment
Gary M. Owens, MD, F. Randy Vogenberg, PhD, FASHP
October 2015 Vol 8, No 7 in Clinical
The Impact of HbA1c Testing on Total Annual Healthcare Expenditures Among Newly Diagnosed Patients with Diabetes
Gary M. Owens, MD, Prajakta Bhounsule, MS, Andrew M. Peterson, PharmD, PhD
September 2015 Vol 8, No 6 in Business
New FDA Drug Approvals Hit an 18-Year High in 2014
Gary M. Owens, MD
March 2015, Vol 8, Sixth Annual Payers' Guide in Payers' Guide
Oncology Pharmacist's Role in Cancer Care
Gary M. Owens, MD
Videos
Cost of Cancer Care and Complexities of Cost-Sharing
Gary M. Owens, MD
Videos
Diagnosis and Treatment of Bipolar Disorders in Adults: A Review of the Evidence on Pharmacologic Treatments
Michael W Jann, PharmD, Gary M. Owens, MD
December 2014 Vol 7, No 9 in Clinical
Introduction - New FDA Drug Approvals in 2013
Gary M. Owens, MD
Special Feature Fifth Annual Payers' Guide to New FDA Approvals March 2014 Volume 7 in Payers' Guide
Fixed-Dose Combination Gel of Adapalene and Benzoyl Peroxide plus Doxycycline 100 mg versus Oral Isotretinoin for the Treatment of Severe Acne: Efficacy and Cost Analysis
Gary M. Owens, MD, Pete Penna, PharmD, Matthew H. Meckfessel, PhD, Norman Preston, PhD
January/February 2014 Vol 7, No 1 in Clinical
Pharmacy Staff Opinions Regarding Diabetic Retinopathy Screenings in the Community Setting: Findings from a Brief Survey
Miranda G. Law, BS, PharmD Candidate, Gary M. Owens, MD, Stephanie Komura, BS, PharmD Candidate, Ann P. Murchison, MD, MPH, Laura T. Pizzi, PharmD, MPH
November/December 2013, Vol 6, No 9 in Clinical
Cancer Care in 2013: Hope, Reality, and a Call to Action
Gary M. Owens, MD
August 2013 Vol 6, No 6 Special Issue in Payers' Perspectives
Rapid Expansion of New Oncology Care Delivery Payment Models: Results from a Payer Survey
Rhonda Greenapple, MSPH, Gary M. Owens, MD
July 2013 Vol 6, No 5 in Business
Introduction: New FDA Drug Approvals in 2012: A 15-Year High
Gary M. Owens, MD
April 2013 Vol 6 No 3 Payers’ Guide to New FDA Approvals in FDA Approvals, Drug Updates, Payers' Guide
The Opportunity for Health Plans to Improve Quality and Reduce Costs by Embracing Primary Care Medical Homes
Sarah Collins, MBA, Jack E. Fincham, PhD, RPh, Kevin B. “Kip” Piper, MA, FACHE, Gary M. Owens, MD
January/February 2013 Vol 6, No 1 in Business
Assessment of Treatment Patterns and Patient Outcomes in Levodopa-Induced Dyskinesias (ASTROID): A US Chart Review Study
Barbara Lennert, RN, BSN, MAOM, Gary M. Owens, MD, Wendy Bibeau, PhD, Eileen Farrelly, MPH, Patricia Sacco, MPH, RPh, Tessa Schoor, MD
September/October 2012 Vol 5, No 6 in Clinical
Anticoagulant Use for Prevention of Stroke in a Commercial Population with Atrial Fibrillation
Aarti A. Patel, PharmD, MBA, Jack E. Fincham, PhD, RPh, Barbara Lennert, RN, BSN, MAOM, Brian Macomson, PharmD, Winnie W. Nelson, PharmD, Gary M. Owens, MD, Samir H. Mody, PharmD, MBA, Jeff Schein, DrPH, MPH
July/August 2012, Vol 5, No 5 in Clinical
Emerging Trends in Cancer Care: Health Plans’ and Pharmacy Benefit Managers’ Perspectives on Changing Care Models
Rhonda Greenapple, MSPH, Gary M. Owens, MD
July 2012, Vol 5, No 4 in Business
Value-Based Care in Cardiometabolic Health: A Medical Director’s Perspective on the Inaugural Edition
Gary M. Owens, MD
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1 in Payers' Perspectives
Primary Care Shortages: Strengthening This Sector Is Urgently Needed, Now and in Preparation for Healthcare Reform
Sarah Collins, MBA, Gary M. Owens, MD
January/February 2012, Vol 5, No 1 in Regulatory
American Health & Drug Benefits: Reflections on the First 5 Years
Gary M. Owens, MD
January/February 2012, Vol 5, No 1 in Editorial
Sensitivity of Medication Use to Formulary Controls in Medicare Beneficiaries: A Review of the Literature
Rahul Shenolikar, PhD, Gary M. Owens, MD, Amanda Schofield Bruno, PhD, MPH, Christopher Cantrell, PhD, Michael Eaddy, PharmD, PhD
November/December 2011, Vol4, No7 in Business
Lipid Management in Patients with Type 2 Diabetes
Marsha J. Daniel, PharmD, cPh, CDE, Gary M. Owens, MD
September 2011, Vol 4, No 5 in Clinical
COPD and Its Associated Costs
Gary M. Owens, MD
Web Exclusives
When Information Is Insufficient: Inspiring Patients for Medication Adherence and the Role of Social Support Networking
Maureen Hennessey, PhD, CPCC, Gary M. Owens, MD, John W. Heryer, MD, FACS
January/February 2011, Vol 4, No 1 in Clinical, Original Research
A Wellness-Based Healthcare System for Chronic Diseases: Prevention, Intervention, and Innovation
Robert E. Henry, Kip Piper, MA, FACHE, F. Randy Vogenberg, PhD, FASHP, Thomas McCarter, MD, FACP, Farrah N. Daly, MD, MBA, Keri Cooper, Nirav R. Shah, MD,MPH, Lawton Robert Burns, PhD, MBA, Gene Reeder, RPh, PhD, Scott Gottlieb, MD, Toni Fera, BPharm, PharmD, Wayne M. Lednar, MD, PhD, Alberto M. Colombi, MD, MPH, Michael F. Murphy, MD, PhD, Gary M. Owens, MD, James T. Kenney, RPh, MBA, J. B. Jones, PhD, MBA, Walter F. Stewart, PhD, MPH
Supplements
Seizing the Opportunity
Gary M. Owens, MD
April 2008, Vol 1, No 3 in Industry Trends
Managed Care and Medicare Use of Generics: Seizing the Opportunity, Part 2
Gary M. Owens, MD
May 2008, Vol 1, No 4 in Industry Trends
Where Generics and Biologics Meet
Melisa J. Heinrichs, PharmD, BSPS, Gary M. Owens, MD
June 2008, Vol 1, No 5 in Industry Trends
The Working Patient with Cancer: Implications for Payers and Employers
Grant D. Lawless, BSPharm, MD, FACP, Gary M. Owens, MD
June/July 2009, Vol 2, No 4 in Business
Physicians' Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care
Alyssa Pozniak, PhD, Gary M. Owens, MD, Lois Olinger, MA, Victoria Shier, MA
January/February 2010, Vol 3, No 1 in Business
Private Health Plans Perspectives: Electronic Personal Health Records and Electronic Prescribing
Nancy M. McGee, JD, MPH, Gary M. Owens, MD, Gene Reeder, RPh, PhD, Timothy S. Regan, BPharm, RPh, CPh, J.D. Kleinke, Steve Arnold, MD, MS, MBA, CPE
September/October 2009, Vol 2, No 6 in Business
Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels
F. Randy Vogenberg, PhD, FASHP, Gary M. Owens, MD
May/June 2010, Vol 3, No 3 in Business
Last modified: April 12, 2019